CD8A and Increased total eosinophil count: No eosinophilia or signs of VLS were detected at any of the dose levels tested, including up to 10-fold higher than that eliciting maximal expansion of peripheral target CD8+ T and NK cells, suggesting a therapeutic index not previously observed, or possible, with aldesleukin (5, 6, 8, 15, 16).